Related references
Note: Only part of the references are listed.Structure of human chromatin-remodelling PBAF complex bound to a nucleosome
Junjie Yuan et al.
NATURE (2022)
Acute BAF perturbation causes immediate changes in chromatin accessibility
Sandra Schick et al.
NATURE GENETICS (2021)
Mammalian SWI/SNF continuously restores local accessibility to chromatin
Mario Iurlaro et al.
NATURE GENETICS (2021)
ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer
Guotai Xu et al.
NATURE GENETICS (2020)
PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma
Xian-De Liu et al.
NATURE COMMUNICATIONS (2020)
Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis
Jun Nishida et al.
NATURE CELL BIOLOGY (2020)
A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response
A. Ari Hakimi et al.
NATURE COMMUNICATIONS (2020)
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade
Robert J. Motzer et al.
CANCER CELL (2020)
Clinical Validation of PBRM1 Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma
David A. Braun et al.
JAMA ONCOLOGY (2019)
High affinity binding of H3K14ac through collaboration of bromodomains 2, 4 and 5 is critical for the molecular and tumor suppressor functions of PBRM1
Lili Liao et al.
MOLECULAR ONCOLOGY (2019)
A central anti-oncogenic pathway in ccRCC
Monica Wang
NATURE REVIEWS NEPHROLOGY (2019)
PBRM1 Regulates Stress Response in Epithelial Cells
Elizabeth G. Porter et al.
ISCIENCE (2019)
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
Samra Turajlic et al.
CELL (2018)
PBRM1 bromodomains variably influence nucleosome interactions and cellular function
Mariesa J. Slaughter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
David F. McDermott et al.
NATURE MEDICINE (2018)
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma
Jing Zhang et al.
SCIENCE (2018)
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing
Deng Pan et al.
SCIENCE (2018)
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Diana Miao et al.
SCIENCE (2018)
Multiple tumor suppressors regulate a hIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer
Lili Liao et al.
ELIFE (2018)
NF-κB, inflammation, immunity and cancer: coming of age
Koji Taniguchi et al.
NATURE REVIEWS IMMUNOLOGY (2018)
SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation
Xiaofeng Wang et al.
NATURE GENETICS (2017)
Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL-/- clear cell renal carcinoma
Wenhua Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis
Judit Espana-Agusti et al.
NATURE COMMUNICATIONS (2017)
VHL Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell Carcinoma
Xiaosai Yao et al.
CANCER DISCOVERY (2017)
Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade
Yi-Feng Gu et al.
CANCER DISCOVERY (2017)
The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma
Amrita M. Nargund et al.
CELL REPORTS (2017)
The pioneer factor OCT4 requires the chromatin remodeller BRG1 to support gene regulatroy element funciton in mouse embryonic stem cells
Hamish W. King et al.
ELIFE (2017)
csaw: a Bioconductor package for differential binding analysis of ChIP-seq data using sliding windows
Aaron T. L. Lun et al.
NUCLEIC ACIDS RESEARCH (2016)
deepTools2: a next generation web server for deep-sequencing data analysis
Fidel Ramirez et al.
NUCLEIC ACIDS RESEARCH (2016)
ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization
Guangchuang Yu et al.
BIOINFORMATICS (2015)
Structured nucleosome fingerprints enable high-resolution mapping of chromatin architecture within regulatory regions
Alicia N. Schep et al.
GENOME RESEARCH (2015)
ngs.plot: Quick mining and visualization of next-generation sequencing data by integrating genomic databases
Li Shen et al.
BMC GENOMICS (2014)
Efficacy of therapy with bortezomib in solid tumors: a review based on 32 clinical trials
Zebo Huang et al.
FUTURE ONCOLOGY (2014)
Requirement for PBAF in Transcriptional Repression and Repair at DNA Breaks in Actively Transcribed Regions of Chromatin
Andreas Kakarougkas et al.
MOLECULAR CELL (2014)
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
Marco Gerlinger et al.
NATURE GENETICS (2014)
ChIP-Enrich: gene set enrichment testing for ChIP-seq data
Ryan P. Welch et al.
NUCLEIC ACIDS RESEARCH (2014)
Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: A phase I trial of bortezomib plus bevacizumab
Gerald S. Falchook et al.
ONCOTARGET (2014)
BAF180 Promotes Cohesion and Prevents Genome Instability and Aneuploidy
Peter M. Brownlee et al.
CELL REPORTS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
NF-κB Forms a Complex with the Chromatin Remodeler BRG1 to Regulate Schwann Cell Differentiation
Allison S. Limpert et al.
JOURNAL OF NEUROSCIENCE (2013)
Target analysis by integration of transcriptome and ChIP-seq data with BETA
Su Wang et al.
NATURE PROTOCOLS (2013)
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
Caryn S. Ross-Innes et al.
NATURE (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Bortezomib Induces Nuclear Translocation of IκBα Resulting in Gene-Specific Suppression of NF-κB-Dependent Transcription and Induction of Apoptosis in CTCL
Ashish Juvekar et al.
MOLECULAR CANCER RESEARCH (2011)
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Ignacio Varela et al.
NATURE (2011)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
Phase II trial of bortezomib for patients with advanced renal cell carcinoma
GV Kondagunta et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Share Paper
